Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Oncology Institute, Inc. (TOI)
NASDAQ:TOI
TOI Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.13 - $2.10
Previous CloseN/A
Volume198.36K
Average Volume (3M)886.67K
Market Cap
$67.54M
Enterprise Value$100.24M
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta1.84
Next Earnings
Mar 06, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.77
Shares Outstanding75,559,074
10 Day Avg. Volume556,467
30 Day Avg. Volume886,666
Standard Deviation0.42
R-Squared0.00196
Alpha0.02
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.18
Price to Cash Flow (P/CF)20.60
P/FCF Ratio40.30
Enterprise Value/Market Cap1.48
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit1.68
Enterprise Value/Ebitda-1.58
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
Oncology Institute, Inc. News
PremiumCompany Announcements
Oncology Institute Reports Strong Revenue Growth Amid Challenges
PremiumCompany Announcements
Oncology Institute Announces Board Changes for 2025
PremiumCompany Announcements
Oncology Institute Announces CFO Transition and Strategic Growth Plan
---
Ownership Overview
4.61% Insiders
2.75% Mutual Funds
12.76% Other Institutional Investors
77.50% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
TOI FAQ
What was Oncology Institute, Inc.’s price range in the past 12 months?
Oncology Institute, Inc. lowest stock price was $0.13 and its highest was $2.10 in the past 12 months.
What is Oncology Institute, Inc.’s market cap?
Oncology Institute, Inc.’s market cap is $67.54M.
When is Oncology Institute, Inc.’s upcoming earnings report date?
Oncology Institute, Inc.’s upcoming earnings report date is Mar 06, 2025 which is in 12 days.
How were Oncology Institute, Inc.’s earnings last quarter?
Oncology Institute, Inc. released its earnings results on Nov 13, 2024. The company reported -$0.18 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.18.
Is Oncology Institute, Inc. overvalued?
According to Wall Street analysts Oncology Institute, Inc.’s price is currently Overvalued.
Does Oncology Institute, Inc. pay dividends?
Oncology Institute, Inc. does not currently pay dividends.
What is Oncology Institute, Inc.’s EPS estimate?
Oncology Institute, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Oncology Institute, Inc. have?
Oncology Institute, Inc. has 75,559,074 shares outstanding.
What happened to Oncology Institute, Inc.’s price movement after its last earnings report?
Oncology Institute, Inc. reported an EPS of -$0.18 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -7.692%.
Which hedge fund is a major shareholder of Oncology Institute, Inc.?
Currently, no hedge funds are holding shares in TOI
---
Oncology Institute, Inc. Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Insider Transactions
Bought Shares
Worth $50.0K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-52.75%
12-Months-Change
Fundamentals
Return on Equity
-131.66%
Trailing 12-Months
Asset Growth
-17.94%
Trailing 12-Months
Company Description
Oncology Institute, Inc.
DFP Healthcare Acquisitions Corp is a blank check company.
---
TOI Earnings Call
Q3 2024
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call highlighted significant revenue growth, strategic expansions, and operational improvements, such as cost reductions and cash surplus. However, challenges remain with net losses, negative adjusted EBITDA, and compliance issues with NASDAQ. Despite these challenges, the positive aspects, especially in revenue and operational efficiencies, suggest a cautiously optimistic outlook.Read More>---
TOI Stock 12 Month Forecast
Average Price Target
―Technical Analysis
Plus Therapeutics
―
Enzo Biochem
―
Sorrento Therapeutics
―
Actinium Pharmaceuticals
―
Citius Pharmaceuticals
―
Best Analysts Covering TOI
1 Year
1 Year Success Rate
1/2 ratings generated profit
1 Year Average Return
+12.80%
reiterated a buy rating 9 months ago
Copying Jack Slevin's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of +12.80% per trade.
---